Immune Checkpoints

Immune Checkpoints is an immunoregulatory receptor–ligand system that modulates the amplitude and duration of antigen-induced lymphocyte activation by delivering co-stimulatory or inhibitory signals, thereby maintaining self-tolerance and immune homeostasis.

5K

Publications

463.6K

Citations

40.4K

Authors

5K

Institutions

Publications per year

2017–2026

4.4K

Authors

40.4K

  1. FS
    F. Stephen Hodi

    Dana-Farber Cancer Institute, United States

    58 publications · 26.9K citations

    47

    h-index

  2. RJ
    Ryan J. Sullivan

    Massachusetts General Hospital, United States

    47 publications · 11.5K citations

    39

    h-index

  3. JD
    Jedd D. Wolchok

    Memorial Sloan Kettering Cancer Center, United States

    42 publications · 27.7K citations

    35

    h-index

  4. GV
    Georgina V. Long

    The University of Sydney, Australia

    47 publications · 19.9K citations

    34

    h-index

  5. DS
    Dirk Schadendorf

    Heidelberg University, Germany

    51 publications · 16.9K citations

    33

    h-index

1–5 of 40.4K

Venues

  1. Journal for ImmunoTherapy of Cancer

    JITC · 254 publications · 18.1K citations

    76

    h-index

  2. Nature Communications

    118 publications · 17.3K citations

    66

    h-index

  3. OncoImmunology

    155 publications · 10K citations

    60

    h-index

  4. Cancer Immunology Research

    97 publications · 9.4K citations

    54

    h-index

  5. Clinical Cancer Research

    76 publications · 10.5K citations

    50

    h-index

1–5